Chinese Journal of Cancer Research

Papers
(The median citation count of Chinese Journal of Cancer Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Esophageal cancer: Epidemiology, risk factors and screening84
Screening for gastric cancer in China: Advances, challenges and visions57
Colorectal cancer burden and trends: Comparison between China and major burden countries in the world51
Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study47
Mn-based cGAS-STING activation for tumor therapy38
Burden of liver cancer: From epidemiology to prevention38
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)33
Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017−203028
Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review27
Update in version 2021 of CSCO guidelines for colorectal cancer from version 202027
CSCO guidelines for colorectal cancer version 2022: Updates and discussions26
National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)25
National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)21
Lung cancer risk in never-smokers: An overview of environmental and genetic factors20
Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression20
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)17
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)17
Surgical treatment of gastric cancer: Current status and future directions16
Landscape of cell heterogeneity and evolutionary trajectory in ulcerative colitis-associated colon cancer revealed by single-cell RNA sequencing14
Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer14
National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)14
Symptom burden in advanced breast cancer patients and its association between death anxiety and psychological distress13
Current status of lymph node dissection in gastric cancer12
Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics12
Contemporary trends on expenditure of hospital care on total cancer and its subtypes in China during 2008−201712
Inducing immunogenic cell death in immuno-oncological therapies12
National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)12
Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma12
Features of colorectal cancer in China stratified by anatomic sites: A hospital-based study conducted in university-affiliated hospitals from 2014 to 201811
Pan-cancer analyses demonstrate that ANKRD6 is associated with a poor prognosis and correlates with M2 macrophage infiltration in colon cancer11
National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version)11
A radiomics prognostic scoring system for predicting progression-free survival in patients with stage IV non-small cell lung cancer treated with platinum-based chemotherapy11
Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia10
Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns10
Stomach cancer burden in China: Epidemiology and prevention10
Open surgery in the era of minimally invasive surgery10
Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial10
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)9
Attributable deaths of liver cancer in China9
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small cell lung cancer: A real-world, multicenter, retrospective, controlled study in China9
Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer9
Prognostic value of a modified Immunosocre in patients with stage I−III resectable colon cancer9
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road9
Current status and future perspectives on neoadjuvant therapy in gastric cancer9
Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts9
Focal ablation therapy presents promising results for selectively localized prostate cancer patients8
TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinoma8
Advances in novel molecular typing and precise treatment strategies for small cell lung cancer8
Deep learning model improves radiologists’ performance in detection and classification of breast lesions7
Development and validation of a CT-based radiomics nomogram for preoperative prediction of tumor histologic grade in gastric adenocarcinoma7
Efficacy and safety of chemotherapy combined with bevacizumab in Chinese patients with metastatic colorectal cancer: A prospective, multicenter, observational, non-interventional phase IV trial7
Single-cell DNA methylome analysis of circulating tumor cells7
Comparative yield and efficiency of strategies based on risk assessment and fecal immunochemical test in colorectal cancer screening: A cross-sectional population-based analysis7
Current status and perspectives of conversion therapy for advanced gastric cancer7
Laparoscopic vs. open surgery for gastrointestinal stromal tumors of esophagogastric junction: A multicenter, retrospective cohort analysis with propensity score weighting7
Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis6
Recent updates and current issues of sentinel node navigation surgery for early gastric cancer6
Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis6
ZNF292 suppresses proliferation of ESCC cells through ZNF292/SKP2/P27 signaling axis6
Effect of preoperative nutrition therapy type and duration on short-time outcomes in gastric cancer patient with gastric outlet obstruction6
Pain threshold, anxiety and other factors affect intensity of postoperative pain in gastric cancer patients: A prospective cohort study6
Epidemiology and early screening strategies for colorectal cancer in China5
Textbook Outcome as a measure of surgical quality assessment and prognosis in gastric neuroendocrine carcinoma: A large multicenter sample analysis5
Heterogeneity of tumor-infiltrating myeloid cells in era of single-cell genomics5
Identification of lymph node metastasis by computed tomography in early gastric cancer5
Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis5
Research advances of secretory proteins in malignant tumors5
All-trans retinoic acid (ATRA) inhibits insufficient radiofrequency ablation (IRFA)-induced enrichment of tumor-initiating cells in hepatocellular carcinoma5
Epidemiology of pancreatic cancer: New version, new vision5
Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma5
Novel technologies in cfDNA analysis and potential utility in clinic5
Associations of centralization with health care quality for gastric cancer patients receiving gastrectomy in China5
Deregulated expression and subcellular localization of CPSF6, a circRNA-binding protein, promote malignant development of esophageal squamous cell carcinoma5
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update5
Vorolanib, an oral VEGFR/PDGFR dual tyrosine kinase inhibitor for treatment of patients with advanced solid tumors: An open-label, phase I dose escalation and dose expansion trial4
Multi-center investigation of breast reconstruction after mastectomy from Chinese Society of Breast Surgery: A survey based on 31 tertiary hospitals (CSBrS-004)4
Coexisting opportunities and challenges: In which scenarios can minimal/measurable residual disease play a role in advanced non-small cell lung cancer?4
Coupling radiomics analysis of CT image with diversification of tumor ecosystem: A new insight to overall survival in stage I−III colorectal cancer4
Challenge and future of cancer screening in China: Insights from esophageal cancer screening practice4
Phase 1 studies comparing safety, tolerability, pharmacokinetics and pharmacodynamics of HLX01 (a rituximab biosimilar) to reference rituximab in Chinese patients with CD20-positive B-cell lymphoma4
Breast cancer: Epidemiology, risk factors and screening4
Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials4
Aqueous-soluble components of sporoderm-removed Ganoderma lucidum spore powder promote ferroptosis in oral squamous cell carcinoma4
Chinese quality control indices for standardized diagnosis and treatment of gastric cancer (2022 edition)4
Detection and classification of breast lesions using multiple information on contrast-enhanced mammography by a multiprocess deep-learning system: A multicenter study4
Clinical characteristics and clinicopathological correlations of bilateral breast cancer in China: A multicenter study from Chinese Society of Breast Surgery (CSBrS-006)4
Laparoscopic surgery for gastric cancer: Current status and future direction3
Pan-cancer tumor-infiltrating T cells: A great hallmark in cancer immunology research3
Psychosomatic symptoms affect radiotherapy setup errors in early breast cancer patients3
A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers3
Current situation of programmed cell death protein 1/programmed cell death ligand 1 inhibitors in advanced triple-negative breast cancer3
Current status and challenges in sentinel node navigation surgery for early gastric cancer3
Striatins and STRIPAK complex partners in clinical outcomes of patients with breast cancer and responses to drug treatment3
Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer3
Genomic landscape of T-cell lymphoblastic lymphoma3
A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma3
Reappraise role of lymph node status in patterns of recurrence following curative resection of gastric adenocarcinoma3
0.039401054382324